top of page
AdobeStock_403024148.jpeg

Regulatory Affairs

Due to rapid changes in regulatory affairs and ever-increasing demands, PRSG offers the following services for you.

Regulatory Support and Strategy 

  • Regulatory advice during early stages of product development

  • Tailored project management for fast approval and trouble shooting

  • Consultation of authorities for scientific advice related to Quality, Non-Clinic and Clinic 

  • Electronic platforms support (CESP, PLM, IRIS, SPOR, UPD, etc.)

  • Support for IMAA in national, mutual recognition, decentralised, and centralised procedures (NP, MRP, DCP, CP)

  • Definition of the appropriate application procedure and product status

  • Submission and procedural management throughout the authorisation process

  • Support in readability testing

  • Evaluation of regulatory and CMC documentation

  • Preparation of expert statements and overviews

  • Support in preparation and preparation of Modules 2–5

  • Development of pharmacological, toxicological, and clinical expert reports, as well as environmental risk assessments

  • eCTD (human) and vNeeS (veterinary) dossier compilation

  • Timely handling of deficiency letters from authorities

  • Compilation and translation of SmPCs and PILs (EN/DE and DE/EN) - national phase

  • Artwork review and quality check

Initial Marketing Authorisation Procedures

Life Cycle Management

  • Human and veterinary medicinal products

  • Radiopharmaceuticals

  • Biological products

  • Literature research

  • Dossier management and revisions

  • Classification, preparation and submission of variations

  • Processing of Follow-up-activities

  • Update of Product Information (SmPC, PIL and Labelling)

  • Preparation of pharmacological and toxicological expert reports, clinical expert reports, environmental compatibility testing, etc.

Radio- pharmaceuticals

  • Customized solutions and strategic consulting

  • Tailored regulatory strategies for radio pharmaceuticals

  • Support during initial marketing authorisation

  • Support throughout the entire product life cycle

Rx to OTC Switch

  • Evaluation of the possibility for OTC switch

  • Evaluation of the impact on reimbursement and pricing

  • Preparation of OTC switch report

  • Preparation of switch dossier

SME Status Submission

  • Preparation of application 

  • Submission of SME Status application at EMA

Translations and Proof Reading

  • Translation of SmPCs, PIL and Labelling from English to German and from German to English

  • Translation of dossier parts from German language to English

  • Proof reading of Product Information (Artwork review)

  • Artwork check

bottom of page